Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition)
In Western developed countries, precision nuclear medicine diagnosis and treatment for neuroendocrine neoplasms (NENs) have been widely adopted in clinical practice. Over the past two decades, China has made significant progress in both research and clinical application of nuclear medicine-based NEN...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-07-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0610 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849392764651831296 |
|---|---|
| author | Chinese Society of Nuclear Medicine in Chinese Medical Association Chinese Neuroendocrine Tumor Society in China International Exchange and Promotive Association for Medical and Health Care |
| author_facet | Chinese Society of Nuclear Medicine in Chinese Medical Association Chinese Neuroendocrine Tumor Society in China International Exchange and Promotive Association for Medical and Health Care |
| author_sort | Chinese Society of Nuclear Medicine in Chinese Medical Association |
| collection | DOAJ |
| description | In Western developed countries, precision nuclear medicine diagnosis and treatment for neuroendocrine neoplasms (NENs) have been widely adopted in clinical practice. Over the past two decades, China has made significant progress in both research and clinical application of nuclear medicine-based NENs management. With internationally approved diagnostic and therapeutic agents soon entering the Chinese market and the ongoing clinical trials of domestically developed innovative drugs, there is an urgent need to establish standardized diagnostic and treatment guideline. To address this, the Chinese Society of Nuclear Medicine and the Chinese Neuroendocrine Tumor Society have collaborated to develop the Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition). The guideline integrates the latest research advances and international recommendations with China's clinical practice, aiming to standardize and optimize NENs management through nuclear medicine in China. |
| format | Article |
| id | doaj-art-43b7ada1eb284ed6b387cb5497cd7a3a |
| institution | Kabale University |
| issn | 1674-9081 |
| language | zho |
| publishDate | 2025-07-01 |
| publisher | Editorial Office of Medical Journal of Peking Union Medical College Hospital |
| record_format | Article |
| series | Xiehe Yixue Zazhi |
| spelling | doaj-art-43b7ada1eb284ed6b387cb5497cd7a3a2025-08-20T03:40:42ZzhoEditorial Office of Medical Journal of Peking Union Medical College HospitalXiehe Yixue Zazhi1674-90812025-07-0116485586610.12290/xhyxzz.2025-0610Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition)Chinese Society of Nuclear Medicine in Chinese Medical AssociationChinese Neuroendocrine Tumor Society in China International Exchange and Promotive Association for Medical and Health CareIn Western developed countries, precision nuclear medicine diagnosis and treatment for neuroendocrine neoplasms (NENs) have been widely adopted in clinical practice. Over the past two decades, China has made significant progress in both research and clinical application of nuclear medicine-based NENs management. With internationally approved diagnostic and therapeutic agents soon entering the Chinese market and the ongoing clinical trials of domestically developed innovative drugs, there is an urgent need to establish standardized diagnostic and treatment guideline. To address this, the Chinese Society of Nuclear Medicine and the Chinese Neuroendocrine Tumor Society have collaborated to develop the Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition). The guideline integrates the latest research advances and international recommendations with China's clinical practice, aiming to standardize and optimize NENs management through nuclear medicine in China.https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0610neuroendocrine neoplasmsprecise nuclear medicine theranosticsclinical guidelinesomatostatin receptor imagingpeptide receptor radionuclide therapy |
| spellingShingle | Chinese Society of Nuclear Medicine in Chinese Medical Association Chinese Neuroendocrine Tumor Society in China International Exchange and Promotive Association for Medical and Health Care Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition) Xiehe Yixue Zazhi neuroendocrine neoplasms precise nuclear medicine theranostics clinical guideline somatostatin receptor imaging peptide receptor radionuclide therapy |
| title | Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition) |
| title_full | Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition) |
| title_fullStr | Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition) |
| title_full_unstemmed | Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition) |
| title_short | Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition) |
| title_sort | clinical guideline for precision nuclear medicine diagnosis and treatment of neuroendocrine neoplasms 2025 edition |
| topic | neuroendocrine neoplasms precise nuclear medicine theranostics clinical guideline somatostatin receptor imaging peptide receptor radionuclide therapy |
| url | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0610 |
| work_keys_str_mv | AT chinesesocietyofnuclearmedicineinchinesemedicalassociation clinicalguidelineforprecisionnuclearmedicinediagnosisandtreatmentofneuroendocrineneoplasms2025edition AT chineseneuroendocrinetumorsocietyinchinainternationalexchangeandpromotiveassociationformedicalandhealthcare clinicalguidelineforprecisionnuclearmedicinediagnosisandtreatmentofneuroendocrineneoplasms2025edition |